Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4297442 (GB-0139, GB0139, Olitigaltin, Olitigaltina, Olitigaltine, Td 139, Td-139, Td139, TD-139, TD139) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Galectin-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4915] [UniProtKB: P09382] | ||||||||
ChEMBL | Binding affinity to human Gal-1 expressed in Escherichia coli BL21 (DE3) by competitive fluorescence polarization assay | B | 5.3 | pKd | 5000 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
ChEMBL | Binding affinity to galectin-1 (unknown origin) assessed as dissociation constant | B | 7.92 | pKd | 12 | nM | Kd | J Med Chem (2023) 66: 16980-16990 [PMID:38059452] |
ChEMBL | Binding affinity to human Gal-1 expressed in Escherichia coli BL21star (DE3) by competitive fluorescence polarization assay | B | 7.92 | pKd | 12 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
Galectin-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4531] [UniProtKB: P17931] | ||||||||
ChEMBL | Binding affinity to human Gal-3 expressed in Escherichia coli BL21 (DE3) cells by competitive fluorescence polarization assay | B | 7.43 | pKd | 37 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
ChEMBL | Binding affinity to human Gal-3 expressed in Escherichia coli BL21star (DE3) cells by competitive fluorescence polarization assay | B | 7.85 | pKd | 14 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
ChEMBL | Binding affinity to galectin-3 (unknown origin) assessed as dissociation constant | B | 8.64 | pKd | 2.3 | nM | Kd | J Med Chem (2023) 66: 16980-16990 [PMID:38059452] |
ChEMBL | Binding affinity at recombinant human Galectin-3 assessed as dissociation constant by fluorescence anisotropy assay | B | 8.66 | pKd | 2.2 | nM | Kd | Bioorg Med Chem (2024) 101: 117638-117638 [PMID:38394996] |
ChEMBL | Inhibition of human Gal3-induced chemotaxis using human monocyte incubated for 4 hrs by calcein-AM dye based assay | B | 7.1 | pIC50 | 80 | nM | IC50 | J Med Chem (2021) 64: 6634-6655 [PMID:33988358] |
ChEMBL | Inhibition of biotin-asialofetuin binding to human Gal3 measured after 90 mins by HTRF competition assay | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2021) 64: 6634-6655 [PMID:33988358] |
Galectin-3 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3668] [UniProtKB: P16110] | ||||||||
ChEMBL | Inhibition of moues Gal3-induced hemagglutination using mouse RBC incubated for overnight by hemagglutination assay | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2021) 64: 6634-6655 [PMID:33988358] |
ChEMBL | Inhibition of biotin-asialofetuin binding to mouse Gal3 measured after 90 mins by HTRF competition assay | B | 7.17 | pIC50 | 67 | nM | IC50 | J Med Chem (2021) 64: 6634-6655 [PMID:33988358] |
Galectin-8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5475] [UniProtKB: O00214] | ||||||||
ChEMBL | Binding affinity to N-terminal domain human Gal-8 expressed in Escherichia coli BL21star (DE3) cells by competitive fluorescence polarization assay | B | 4.07 | pKd | 86000 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
ChEMBL | Binding affinity to C-terminal domain human Gal-8 expressed in Escherichia coli BL21 (DE3) cells by competitive fluorescence polarization assay | B | 4.67 | pKd | 21600 | nM | Kd | ACS Med Chem Lett (2023) 14: 1257-1265 [PMID:37736168] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]